BSN Capital Partners’s BeOne Medicines ONC Stock Holding History
Bought
Maintained
Sold
Other funds holding ONC
BBA
BSN Capital Partners's ONC Position: Q1 2022 in Review
BSN Capital Partners sold out of BeOne Medicines (ONC) in Q1 2022, closing a stake of 43,400 shares — an estimated $11.8M sold.
BSN Capital Partners first reported a position in ONC in Q4 2021 and held it in 1 quarter. The position peaked at $11.8M in Q4 2021. 239 funds tracked by Wall St. Rank hold ONC as of Q1 2022.
- BSN Capital Partners reported no remaining BeOne Medicines position as of Q1 2022 after selling out during the quarter.
- BSN Capital Partners sold 43,400 BeOne Medicines shares in Q1 2022, an estimated $11.8M.
- BSN Capital Partners first reported a position in BeOne Medicines in Q4 2021 and held it in 1 quarter.
- BSN Capital Partners's BeOne Medicines position peaked at $11.8M in Q4 2021.
- 239 funds tracked by Wall St. Rank held BeOne Medicines as of Q1 2022.
Based on BSN Capital Partners's 13F filing for Q1 2022.